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Abstract
Background: Bee honey is a functional food which has a unique composition, antimicrobial
properties and bifidogenic effect. In order to assess whether honey can inhibit the toxic effect of
mycotoxins, the present study was undertaken.
Methods: Production of biomass and toxins by Aspergillus parasiticus and Aspergillus ochraceus were
followed in media without and with honey. Although aflatoxins and ochratoxin A. were
administrated to male Swiss albino mice up to 1 µg and 10 ng/kg body weight/day respectively. The
experimental animals were fed diets without our with 10% honey for two months. The changes in
colonic probiotic bacteria, determintal colon enzyme glucuronidases, and genotoxicity were
followed.
Results: Addition of 32% in its media increased the biomass of A parasiticus, while the biomass of
A. ochraceus decreased and Ochratoxin A. was not produced. When the honey was added at the
ratio of 32 and 48% in the medium. No relationship was found between mycelium weight and
production of mycotoxins. Oral administration of aflatoxins (mixture   of B1, B2, G1 and G2) and
Ochratoxin A. induced structural and numerical   chromosomal aberrations in bone marrow and
germ cells of male mice, whereas,   honey treatment reduced the genotoxicity of mycotoxins.   Also
both toxins induced histopathological changes in liver and kidney. Feeding on diet supplemented
with honey improved the histopathological changes in case of aflatoxin group, but not in the case
of ochratoxin A. group (except of kidney in two cases). No significant differences were found in
the activity of colon β-glucuronidase between group fed diet with or without honey. On the other
hand, the colon bifido bacteria and lactobacilli counts were increased markedly in group receiving
diet supplemented with honey.
Conclusion: Substituting sugars with honey in processed food can   inhibit the harmful and
genotoxic effects of mycotoxins, and improve the gut   microflora.
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Background
Foods are no longer appreciated by consumers only in
terms of its taste and immediate nutritional needs, but
also in terms of its ability to provide specific health bene-
fits. Functional foods became an important food sector
promoting health benefits via functional ingredients in
these products. Functional foods targeted towards
improving the balance and activity of the intestinal milieu
currently provide the largest segment of functional food
market [1,2].
For a long time, it has been observed that honey can be
used to overcome liver, cardiovascular and gastrointesti-
nal problems [3]. Honey is a natural product with very
complex chemical composition. It is composed primarily
of fructose and glucose but also contains 4 to 5% fructoo-
ligosaccharides which serve as prebiotic agents [4]. It con-
tains more than 180 substances, including amino acids,
vitamins, minerals and enzymes [5]. The antimicrobial
properties of hydrogen peroxide and non-peroxide com-
ponents for honey were tested in several studies [6].
The occurrence of mycotoxins (aflatoxins and ochratoxin)
contamination is global. It's estimated that one quarter of
the world's crops are contaminated to some extent with
mycotoxins, especially prevalent in developing countries.
Generally, mycotoxins are commonly found in foods
[7,8]. Mycotoxins are of great concern because of their det-
rimental effects on the health of humans and animals.
Aspergillus flavus and  A. parasiticus produce aflatoxins.
Ochratoxin A was discovered as a metabolite of Aspergillus
ochraceus. Of the Aspergillus toxins, only ochratoxin (a
natural carcinogen and nephrotoxin) is potentially as
important as aflatoxins (a natural carcinogen). Both of
them are associated with both toxicity and carcinogenicity
in human health. A leading figure in the risk assessment
field ranked mycotoxins as the most important chronic
dietary risk factor, higher than synthetic contaminants,
plant toxins, food additives, or pesticide residues [7,9].
Food contaminants entering the body through the oral
route are directly exposed to the action of gut microflora.
Gastrointestinal (GI) microflora is increasingly being rec-
ognised as one of the factors that influence human health.
This microflora is a dynamic equilibrium that may be
altered by diet [10]. Normal healthy intestinal microflora
contains many strains of lactic acid bacteria (LAB) some
of, which have been isolated, ascribed several beneficial
effects, and termed probiotic strains [11]. Several studies
showed that colonic probiotic bacteria can remove myco-
toxins via physical binding as a mechanism for mutagen
removal [12-14]. In addition to, the severity of mycotox-
ins poisoning can be amplified by factors such as vitamin
deficiency, caloric deprivation, alcohol abuse and infec-
tious disease status [7].
In addition, there is evidence that colonic probiotic bacte-
ria may positively modulate certain colon microbial
enzymes that may play a role in diet-related diseases.
Alteration of these parameters are indicative of protective
effects against carcinogen. Probiotic bacteria bind muta-
gens in vitro, and also they prevent excretion of mutagens
in humans. However, more research is necessary to deter-
mine the physiological significance of endogenous
colonic probiotic bacteria [15].
Complete elimination of any natural toxin from foods is
an unattainable objective. Nutritional science has been
expanding the knowledge of how foods influence con-
sumers in relation to specific health parameters.
Therefore, it is necessary to perform more in-depth studies
to elucidate the potential of protective activities by honey,
through its antifungal activities and reducing dietary-
related chronic diseases, such as cancer.
To achieve this goal, we studied in vitro, the effect of honey
on the growth of fungi and formation of mycotoxins by
Aspergillus in foods. In addition, we studied the effect of
honey in vivo in presence of mycotoxin on endogenous
colonic probiotic bacteria, colon microbial enzymes, cell
proliferation and genotoxicity.
Methods
A monofloral honey (Cotton) was purchased from the
Bee Research Center, Ministry of Agriculture, Cairo, Egypt.
Peanuts (Archis hypogalal) with damage and observable
contamination with fungi were obtained from peanut
main supplier's sources in Egypt. Bacterial culture,
deMann, Rogosa, Sharpe (MRS) medium (Oxoid, Hamp-
shire, United Kingdom) for Lactobacilli. Tryptone Phy-
tone Yeast (TPY) medium (Oxoid) for Bifidobacteria.
ochratoxin A standard (Cat. No. 01877) were purchased
from Sigma-Aldrich chemical company (St. Louis, U.S.A).
Aflatoxins and ochratoxin A producing fungi, A. parasiticus
(FRR 2748) and A. ochraceus (NRRL 3174) were obtained
from Standards Association of Australia (North Sydney,
NSW, Australia). Natural aflatoxins (B1, B2, G1 and G2)
were extracted from peanuts [16] and its concentrations
were determined by thin layer (TLC) and high perform-
ance liquid chromatography (HPLC) techniques [17].
The concentration of extracted aflatoxins B1, B2, G1 and G2
from peanuts were 211.42, 135.53, 368.10 and 99.72 µg/
kg, respectively. The obtained extract was dissolved in 2-
liter soybean oil and stored in the refrigerator until used.
Investigating the effect of honey on mycotoxin production
A. parasiticus (FRR 2748) and A. ochraceus (NRRL 3174)
were cultivated on potato dextrose agar for 10 days at
25°C until they were well sporulated. The spores wereBMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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harvested in 10 ml of sterile 1% Tween 80 solution (V/V)
to give 105 spores/ml. Flasks containing 500 ml of Yeast-
Extract-Sucrose medium (YES) supplemented with zero,
32 and 48% honey were inoculated with 2.0 ml of this
suspension incubated at 28°C for 21 days and then
assayed for aflatoxins [18,19].
Investigating the effect of honey on mycotoxin ingestion in 
mice
Forty-two male Swiss albino mice, approximately 7 weeks
old and weighing 20 ± 3 g, were obtained from the Animal
House Colony at the National Research Center, Cairo,
Egypt. Animals were individually housed in stainless steel
cages under controlled temperature (24–26°C), humidity
(40–70%) and lighting conditions (12 hr light/dark cycle)
and allowed free access to distilled water and basic diet
(AIN-93 M) for 10 days as an adaptive period. The AIN-93
M powder contained, protein (14%), starch (62.07%),
sucrose (10%), fat (4%), fiber (5%), mineral mixture
(3.5%), vitamin mixture (1%), L- cystine (0.18%),
choline bitratrate (0.25%) and tetra-butylhydroquinone
(0.00008%) [20].
The mice were then divided randomaly into six groups (7
animals each). The 1st group received AIN-93 M diet and
administered ochratoxin A (10 ng/kg bw/day, OT group).
The 2nd group were treated the same as group 1 except that
it received honey/AIN-93 M diet (HOT group). Group 3
(AT) and H (HAT) were fed AIN-93 M and honey/AIN-93
M diet respectively and administered aflatoxins mixture (1
µg/kg bw/day). Group 5 (NTC) and 6 (HTC) served as
controls and were fed AIN-93 M and honey AIN-93 M diet
respectively. The experiment was carried out for 2 months,
and animals were weighed weekly to calculate the daily
dose. Animals were injected intraperitoneally with 0.5 ml
of 0.05 % colchicine 2 hours before sacrifice to arrest the
cells of bone marrow and spermatocyte in the metaphase
stage following an overnight fast. The caecum contents
were collected in clean Eppendorf tubes. Femur, liver, kid-
ney, spleen, lung, testis and brain were removed.
Activities of colon microbial enzymes
Bacterial β-glucuronidase activity was assayed in the cae-
cum content digesta with P-nitrophenyl-β-D-glucuronide
(Fluka, product No. 73677) [21]. Caecum dilution was
performed at 4°C. The reaction mixture contained 0.3 ml
substrate solution (5 mol P-nitrophenyl-β-D-glucuro-
nide/l) and 0.2 ml of the diluted caecum (1 part of cae-
cum and 2 parts phosphate buffer pH 6.4, w/v) and mixed
well, incubated at 37°C/48 hrs. The concentration of
released P-nitrophenol was measured from to the optical
absorption at 400 nm after addition of 2.5 ml NaOH 0.1
N to stop reaction. Enzyme activity was expressed as mol
product formed/g caecum content.
Chromosomal aberrations examination
Chromosomes were prepared, stained with 5% Giemsa
stain in phosphate buffer (pH 6.8), and 50 metaphase
spreads were analyzed per animal for chromosomal aber-
rations in bone marrow cells [22]. Also chromosomal
aberrations in germ cells were examined from testis of the
same animals [23].
Histopathlogical examination
Biopsies from liver, kidneys, spleens, lungs and brain were
fixed in 10% buffered formalin solution for 12 hrs and
processed into paraffin blocks. Five-mm thick tissue sec-
tions were cut on albuminzed glass slides and stained
with haematoxylin and eosin stain (Hx. & E.). For proper
evaluation of tissue fibrosis and better demonstration of
blood vessels in tissue sections, massons trichrome stain
was also used [24].
Colonic probiotic bacteria investigations
The endogenous populations of colonic probiotic bacteria
(Lactobacilli and Bifidobacteria) were counted. Caecum
content samples were collected at the end of the experi-
ment from each animal. The caecum content samples
were immediately (within 30 min) placed in an anaerobe
jar and kept at 4°C until analysed (a maximum of 6 hrs).
Hundred fold serial dilutions were performed in pre
reduced Ringer solution containing 0.5% of cystein. Petri
dishes of various media were inoculated and incubated
for 72 hrs at 37°C in anaerobic atmosphere using Gen
Kits in Oxoid jars. Bacteria were detected on selective
media as follows: deMan, Rogosa, Sharpe (MRS) medium
(Oxoid, Hampshire, United Kingdom) for Lactobacilli
and Tryptone Phytone Yeast (TPY) medium (Oxoid) for
Bifidobacteria. After incubation, the colonies were
counted. Bacterial counts are expressed as log10 colony
forming units (log10CFU/g) of fresh caecum content sam-
ple, with detection limit 3.30 log10CFU/g.
Statistics
All data were expressed as mean ± standard error (SEM) of
the mean and analyzed by one way analysed of variance
ANOVA using the SAS statistical programme (SAS version
6.11, SAS Institute, Cary, NC). When significant, Dun-
can's Multiple Range test was used to compare differences
between means. The levels of significance were checked.
Results
Effect of honey on mycotoxin production
The in vitro investigations have shown that the biomass of
A. parasiticus was enhanced in the medium containing
32% honey. However, biomas of A. ochraceus was
decreased in medium containing 32 and 48% honey.
Ochratoxin A was not produced at either honey concen-
trations. On the other side, aflatoxins B1, B2, G1 and G2
production was increased in medium containing 32%BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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honey but decreased in medium of high honey concentra-
tion with no production of aflatoxin B2 and G2 (Table 1).
Generally we did not find any positive relationship
between mycelium weight and mycotoxins production.
Effect of honey on colonic glucuronidases activity
The effects of endogenous colonic probiotic bacteria on
bacterial β-glucuronidases activity in the caecum content
are shown in table 2. The level of glucuronidases was very
low and no significant differences were observed in its in
caecum content between all groups (P < 0.05).
Genotoxic effects of mycotoxins on bone marrow cells
The present study revealed that the oral administration of
aflatoxins (B1, B2, G1 & G2) and ochratoxin A to male mice
induced structural and numerical chromosomal aberra-
tions (Table 3 & Figure 1).
Structural chromosomal aberrations were recorded as
chromatid gaps, chromatid breaks (Figure 1c), centro-
meric attenuations (Figure 1a), deletions (Figure 1b) and
fragments (Figure 1c). Table 3, represents the mean values
of different structural chromosomal aberrations induced
by mycotoxins in bone marrow cells of male mice. The
results show low frequency in chromatid gaps, breaks and
fragments, whereas the frequency of centromeric attenua-
tion were significantly high between AT group and HAT
group from one side and between AT group and the con-
trol groups (NTC and HTC) from the other side.
A significant difference (P < 0.05) was also found in dele-
tions (Figure 1b) between OT group and HOT group, also
between OT group and the control groups (NTC and
HTC), which can be attributed to the protective effect of
honey.
Significant increase (P < 0.05) in the frequency of total
structural chromosomal aberrations was found between
OT group and HOT group from one side and between
group OT and the control groups (NTC and HTC) from
another side. Also, a significant difference was found
between AT group comparing to HAT group and the con-
trol groups (NTC and HTC), respectively.
Genotoxic effects of mycotoxins on germ cells 
(spermatocytes)
The results of our study revealed that oral treatment with
ochratoxin A and aflatoxins (B1, B2, G1 & G2) induced
numerical and structural chromosomal aberrations in
germ cells of male mice (Table 4). Numerical aberrations
were recorded as peridiploidy (n ± 1 or n ± 2) and poly-
ploidy (Figure 1d). Peridiploidy observed in spermato-
cytes of male mouse was clearly different (p ≤ 0.5) only in
the aflatoxins treated group (AT) compared to the control
groups (NTC and HTC). However, polyploidy induced by
ochratoxin A treated group (OT) differed significantly (P
< 0.05) when compared to the control groups. Mean-
while, the total numerical aberrations were significantly
different (P < 0.05) in both ochratoxin A (OT group) and
aflatoxins treated group (AT) in comparison to the control
groups (NTC and HTC). The protective effect of honey
was apparent only in HAT group.
Treatment with ochratoxin A highly induced structural
chromosomal aberrations especially x-y univalents (Fig-
ure 1f), where significant difference (P < 0.05) was found
between OT and HOT groups, also between OT and the
control groups (HTC).
Table 1: Effect of honey on mycelium mass and mycotoxins concentration.
Honey % Mycelium weight (g) Mycotoxins concentration (µg/l)
FRR 2748 NRRL 3174 Aflatoxins Ochratoxin A
B1 B2 G1 G2
0 25.71 14.69 12.69 8.99 7.70 5.00 32.03
32.10 40.40 13.60 15.00 12.34 10.60 6.18 00.00
48.15 30.00 10.00 5.80 00.00 1.18 00.00 00.00




OT HOT AT HAT NTC HTC
0.39 ± 0.11 0.40 ± 0.12 0.32 ± 0.10 0.37 ± 0.10 0.38 ± 0.14 0.42 ± 0.13BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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Effect of honey on cell proliferation
Microscopic examination of the control liver tissue
showed hexagonal hepatic lobules consisting of central
vein from which hepatic cords, sinusoids lined by radiat-
ing kupffer cells as well as bile canaliculi were apparent.
The portal tract was located between three hepatic lobules
and consisted of portal vein, hepatic artery and bile duct
(Figure 2).
Administration of ochratoxin A affected the liver tissue as
it induced dilated congested central veins, with marked
sinusoidal dilation, congestion and hyperplastic kupffer
cells (Figure 4). Also focal hepatic necrosis, predomi-
nantly perivascular was evident (Figure 3). Administra-
tion of honey with ochratoxin A revealed no beneficial
effect as the liver in AOT group was affected the same as in
group OT. On the other hand, administration of aflatox-
ins caused cloudy swelling in hepatocytes, extensive vari-
able side necrotic areas affecting the hepatic parenchyma
and infiltrated by neutrophils and macrophages (Figure
5). Also, congested dilated central veins and marked sinu-
soidal dilatation with hupffer cell hyperplasia were also
evident (Figure 6). The portal tracts are thickened by
mononuclear inflammatory cells formed mainly of lym-
phocytes and telangiectatic, congested vascular channels
(Figure 7).
Histopathlogical examination of the control kidney tis-
sues showed glomeruli, proximal and distal convoluted
renal tubules, the medulla contained the collecting
tubules and parts of the ascending and dexcending loop of
henle. Ochratoxin A administration induced cloudy swell-
ing of proximal convoluted tubules, fibrin thrombin
within glomerular capillary loops, increased number and
size of glomeruli (Figure 8) and interstitial fibrosis and
congestion (Figure 9). On the other hand, co-administra-
tion of honey with ochratoxin A ameliorated the effect of
ochratoxin A on the kidney where vascular congestion
returned to normal. However, they were still slightly
enlarged (Figure 10). Administration of aflatoxins
induced cloudy swelling of the epithelial lining of renal
tubules with mild interstitial fibrosis and congestion (Fig-
ure 11).
Table 3: Mean values of different types of chromosomal aberrations in bone marrow cells of male mice treated with ochratoxin A and 
aflatoxins (B1, B2, G1 and G2).










OT 2.50 ± 0.45a 0.67 ± 0.17a 0.67 ± 0.21a 0.83 ± 0.17b 2.50 ± 0.00a 0.83 ± 0.21a 5.50 ± 0.31b
HOT 1.83 ± 0.33a 0.50 ± 0.00a 0.50 ± 0.00a 0.50 ± 0.00b 0.83 ± 0.21b 0.67 ± 0.17a 3.00 ± 0.34c
AT 2.83 ± 0.67a 0.67 ± .017a 0.67 ± 0.17a 4.33 ± 1.31a 1.17 ± 0.21b 0.83 ± 0.21a 7.67 ± 0.48a
HAT 2.50 ± 0.36a 0.50 ± 0.00a 0.50 ± 0.00a 0.67 ± 0.17b 1.00 ± 0.22b 0.50 ± 0.00a 3.17 ± 0.21c
NTC 2.00 ± 0.22a 0.50 ± 0.00a 0.50 ± .0.00a 0.50 ± 0.00b 0.83 ± 0.21b 0.50 ± 0.00a 2.83 ± 0.21c
HTC 2.00 ± 0.34a 0.50 ± 0.00a 0.50 ± 0.00a 0.50 ± 0.00b 0.67 ± 0.17b 0.50 ± 0.00a 2.67 ± 0.17c
- Means with different superscript letters (a, b, c) are significantly different (P ≤ 0.05).
-All data are expressed as means ± SEM.
Table 4: Mean values of different types of chromosomal aberrations in spermatocyte cells of male mice treated with ochratoxin A and 
aflatoxins (B1, B2, G1 and G2).
Treated groups Numerical aberrations Structural aberrations
Peridiploidy Polyploidy Total X-Y univalents Autosomal 
univalents
Total
OT 1.75 ± 0.48ab 3.75 ± 0.48a 5.25 ± 0.48a 2.75 ± 0.48a 1.00 ± 0.41a 3.75 ± 0.86a
HOT 1.50 ± 0.29abc 2.75 ± 0.25a 4.50 ± 0.65ab 1.00 ± 0.41b 0.75 ± 0.25a 1.75 ± 0.63a
AT 2.25 ± 0.25a 1.25 ± 0.25b 3.50 ± 0.29b 2.00 ± 0.92ab 0.75 ± 0.75a 2.75 ± 0.95a
HAT 1.50 ± 0.29abc 0.50 ± 0.50b 2.00 ± 0.0.41 1.50 ± 0.29ab 0.50 ± 0.29a 2.00 ± 0.58a
NTC 0.75 ± 0.48bc 1.00 ± 0.41b 1.50 ± 0.29c 1.50 ± 0.29ab 1.00 ± 0.41a 2.50 ± 0.29a
HTC 0.50 ± 0.29c 0.25 ± 0.25b 1.00 ± 0.41c 1.00 ± 0.14b 1.00 ± 0.00a 2. 00 ± 0.00a
Within a column, values with no common superscript are significantly different (P ≤ 0.05).
-All data are expressed as means ± SEM.BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
Page 6 of 13
(page number not for citation purposes)
Metaphase spreads of male mice treated with ochratoxin A and aflatoxins showing: a) centromeric attenuation Figure 1
Metaphase spreads of male mice treated with ochratoxin A and aflatoxins showing: a) centromeric attenuation. b) deletion. C) 
chromatid break (small arrow), fragment (large arrow) of bone marrow cells and d) polyploidy. e) autosomal univalent. F) x-y 
univalent, of spermatocyte cells.BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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Regarding the effect of ochratoxin administration on
brain, histopathlogical examination pointed to the pres-
ence of focal areas of degeneration (Figure 12), while Co-
administration of honey with ochratoxin A ameliorated
this effect. In addition, administration of aflatoxin did not
induce any changes in brain tissue.
Histopathlogical examination of the control lung showed
thin alveolar walls, consisted of epithelial cells in both
sides of centrally, located capillaries with no intervening
connective tissue stroma. Administration of ochratoxin A
affected the lung tissues where, the lung showed edema,
congestion, lymphoid aggregates in interstitial tissue (Fig-
ure 13). The results pointed out that the lung showed
relief of congestion (co-administration of honey with
ochratoxin A) (Figure 14). Whereas, the lungs showed
interstitial fibrosis and inflammatory infiltrate after
administration of aflatoxin (Figure 15).
The control spleen tissue showed connective tissue frame-
work (which includes capsule, trabeculae and reticular
connective tissue) and a parenchyma of lymphoid tissue
in the form of white (lymphoid nodules) and red pulp
(Figure 16). Figure 17 illustrated the effect of ochratoxin A
on the spleen where it showed expansion of the white
Liver of NTC group Figure 2
Liver of NTC group. Normal liver tissue (H x. & E. ×100).
Liver of OT group Figure 3
Liver of OT group. Dilated congested central veins marked 
sinusordal dilatation & congestion (Hx. & E. ×200).
Liver of OT group Figure 4
Liver of OT group. Focal hepatic necrosis predominantly peri 
vascular (Hx. & E. ×200).
Liver of AT group Figure 5
Liver of AT group. Variable-sized necrotic areas of the 
hepatic parenchyma infiltrated by neutrophils.(Hx. & E. 
×100).BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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pulp with destruction of normal architecture, adventitial
thickening of arterioles, adventitial thickening of arteri-
oles focal fibrosis of the red pulp and compression of the
sinusoids.
On the other hand administration of aflatoxins did not
indicate any change in the spleen tissue. Co-administra-
tion of honey with aflatoxins causes improvement of all
histopathologic changes that occurred in all examined
organs except for kidney tissue.
Effect of honey on colonic probiotic bacteria
Addition of honey to AIN-93 M powder diet (HTC group)
increased the counts of bifidobacteria by a mean of 2.3 ±
0.23 log10CFU/g (p < 0.004) and lactobacilli by a mean of
1.07 ± 0.35 log10CFU/g (p < 0.016) in comparison to NTC
group (Table 5).
Administration of ochratoxin A in to the group receiving
honey (HOT group) increased the counts of lactobacilli
by a mean of 0.75 ± 0.15 log10CFU/g (p < 0.108) in com-
parison to OT group. Lactobacilli were not detected in the
case of aflatoxins administration (HAT & AT groups)
(Table 5).
Administration of ochratoxin A and aflatoxins mixture in
presence of honey (HOT & HAT groups) increased the
mean counts of bifidobacteria by 1.03 ± 0.32 log10CFU/g
(p < 0.083) and 0.57 ± 0.50 log10CFU/g (p < 0.219) in
comparison to OT and AT groups, respectively.
Discussion
Effects of honey on mycotoxin production
Our results indicate that, the effect of honey on the bio-
mass and mycotoxins formation (in vitro) was depend on
the kind of fungi (A. parasiticus and A. ochraceus) and the
Liver of AT group Figure 6
Liver of AT group. Congested dilated centeral veins and 
marked sinusoidal dilatation (Hx. & E. ×400).
Liver of AT group Figure 7
Liver of AT group. Portal tracts thickened by marked dilata-
tion & congestion of vascular channels and mild mano-
nuclear inflammatory infiltrate (Hx. & E. ×400).
Kidney of OT group Figure 8
Kidney of OT group. Increased number & size of glomeruli 
(Hx. & E. ×100).
Kidney of OT group Figure 9
Kidney of OT group. Interstitial fibrosis and congestion (Mas-
sons trichrome ×100).BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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concentration of honey. The antimicrobial properties of
hydrogen peroxide and non-peroxide components for
honey were reported in several studies [25]. Thus for these
2 types of fungi, honey neutralized more pathogens in
dose-dependent fashion than did a control sugar solution
(80%), consisting of fructose and glucose, similar to that
in pure honey [25]. Undiluted honey inhibited com-
pletely the growth of common fungi of superficial infec-
tion and wound contamination (Aspergillus fumicgatus, A
flavus, Penicellum citrinum, Trichophyton rubrum and Cand-
ida albicans), partial inhibition with honey concentration
of 50% and no inhibition was recorded by honey concen-
tration of 20% [26].
Effect of honey on colonic probiotic bacteria
Lactobacilli and bifidobacteria have complex nutritional
requirements such as carbohydrates, aminoacids, pep-
tides, fatty esters, salts, nucleic acid derivatives, and vita-
mins, which vary markedly from species to species. Honey
contains more than 180 substances, including amino
acids, vitamins, minerals and enzymes [5]. The principal
carbohydrate constituents of honey are fructose (32.56
%) and glucose (28.54 %). In addition to oligosaccha-
rides (1.58 to 3.77% maltose, 0.78 ± 2.03% turanose,
1.11 ± 2.81% nigerose, 0.05 ± 0.15% meli-biose, 0.03 ±
0.08% panose, 0.24 ± 1.03% maltotriose, 0.21 ± 0.37%
melezitose and 0.10 ± 0.25%. Honey also contains 4 to
5% fructooligosaccharides, which serve as probiotic
agents [4].
The normal human small intestine mucosa may incom-
pletely absorb fructose. Several studies have shown that
prevalence of fructose malabsorption in normal adults
may be as high as 30–50%, these subjects may malabsorb
an appreciable amount of a 25 g-fructose dose [27]. The
most normal subjects malabsorb about 10% of carbohy-
drates in honey [28]. Honey oligosaccharides with low
Kidney of HOT group Figure 10
Kidney of HOT group. Return to normal except for vascular 
congestion (Hx. & E. ×200).
Kidney of AT group Figure 11
Kidney of AT group. Cloudy swelling of epithelium of tubules 
(Hx. & E. ×100).
Brain Figure 12
Brain. Focal areas of degeneration in the OT group (Hx. & E. 
×100).
Lung of OT group Figure 13
Lung of OT group. Edema, congestion, lymphoid aggregates 
of interstitial tissue (Hx. & E. ×100).BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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degree of polymerization have been considered as favora-
ble bifidobacterial substrate [10]. Finally, the non-digest-
ible and/or the non-absorbable saccharides move to the
colon to induce selective fermentation, and selective stim-
ulation of the growth and activity of colonic probiotic
bacteria as found previously [29].
The present study confirms the simulative effect of honey
on colonic probiotic bacteria. The growth of intestinal
Bifidobacteria spp. was enhanced with presence of more
than lactobacilli spp, which may be due to the honey oli-
gosaccharides with low degree of polymerization (4 to
5%).
The decrease in the count of colonic probiotic bacteria
with the administration of mycotoxin and in absence or
presence of honey may be due to the changes in the bac-
terial surface during growth phase, as a result of mycotox-
ins binding [13].
Effect of honey on colon bacterial enzyme activities
The level of glucuronidases is an important surrogate for
the effects of diet on the composition and activity of the
intestinal microflora. It is involved in formation as well as
inactivation of carcinogens in the gut lumen and may be
altered in a positive way by the presence of colonic probi-
otic bacteria [30].
The antigenotoxic effects of honey
Mycotoxins were found to be genotoxic to bone marrow
and spermatocyte cells of mice, which coincide with pre-
vious reports [31,32], that the ochratoxin A and aflatoxins
induced chromosomal aberrations in many mammalian
cells (mouse, rat, Chinese hamster and even human
being).
Lung of HOT group Figure 14
Lung of HOT group. Relief of congestion but edeme & lym-
phocytic aggregates are still present (Hx. & E. ×100).
Lung of AT group Figure 15
Lung of AT group. Showing interstitial fibrosis, inflammatory 
infillate with focal lymphocytic aggregates (Massons tri-
chrome ×100).
Spleen of NTC group Figure 16
Spleen of NTC group. Induced similar histopathlogical, white 
& red pulps. (Hx. & E. ×100).
Spleen of OT group Figure 17
Spleen of OT group. Expansion of the white pulp with oblit-
eration of normal architecture (Hx. & E. ×100).BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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Using ochratoxin A and aflatoxins mixture as toxic and
carcinogens, we have characterized the potential antigen-
otoxicity of honey. Honey was antigenotoxic (in vivo), and
that effect was dependent on colonic probiotic bacteria
and other factors. Colonic probiotic bacteria are proposed
to have several beneficial effects, including the inactiva-
tion of carcinogen [15]. In addition to finding that colonic
probiotic bacteria have antigenotoxic properties, it also
immediate interest to study the mechanisms responsible
for its protection. It has been suggested that a protein
structure of bacterial lipopolysaccharides membrane
could be an effective component [33]. Also, there have
been several reports that lactic acid bacteria (LAB) can
bind mutagens and thus may decrease mutagenicity [34].
Nutritional factors found in honey could be used to pre-
vent and eliminate aflatoxins induced mutation [35]. This
was in accordance with our findings, which revealed,
could be prevent or reduce the chromosomal aberrations
induced by aflatoxins. In addition, AFB1- induced DNA
damage and chromosomal aberrations in rodent and
human cells can be modulated by a variety of factors
including nutrients and chemopreventive agents [36].
Those are in agreement with our results, where the admin-
istration of honey could improve the genetic materials
and minimize the chromosomal aberrations induced by
mycotoxins.
Effect of honey on cell proliferation
The present results concerning the histopathological study
revealed that ochratoxin A induced haemorrhage and
necrosis of the red pulp of the spleen. This finding was in
accordance with the work done by [30]. Furthermore,
necrosis in the white pulp, involved cortical and medullry
regions of lymphoid follicles. In addition, ochratoxin A is
connected with an impairment in the structure and func-
tion of brain cell membrane [31]. It may increase, mark-
edly the activities of the cytosolic and lysosomal enzymes.
In the present study, the effect of aflatoxins on the liver
agrees with the work done before [32] whhich explained
this affect to an increase in cytoplasmic easihophilia and
loss of cytoplasmic granularity of hepatocytes. Also, peri-
oprtal fibrosis with degeneration and ulceration of bile
duet epithelial cell lining and proliferation of bile ducts
were recorded [33]. Multifocal, randomly distributed
areas of hepatic necrosis infiltrated with neutrophils and
macrophages were evident. The lesions were central being
more pronounced around portal and similar result [34].
The results of the present work are in accordance with pre-
vious reported [35], that indicating rats treated by intra-
peritoneal injection of Aflatoxin B1 showed pronounced
inflammatory reaction in their lungs, congestion, destruc-
tion of alveolar walls with amphysematous changes and
thickening of the walls of the blood vessels, occurring in
patchy areas of the lung tissue.
From the histopathologic study it can be concluded that
the addition of honey to ochratoxin A improved slightly
the microscopic changes of kidney tissue only. However,
addition of honey aflatoxins improved the histopatho-
logic changes caused by the toxin, in different organs
except for kidney tissue.
Our results indicated that, the detrimental effects of myco-
toxins can be decreased in presence of honey, which may
be via, the detoxification of mycotoxins by probiotic bac-
teria.In the same time, the accessibility of bound AFB1 to
an antibody suggests that surface components of these
bacteria were involved in toxin binding [13]. Variation in
temperature (4 to 37°C) and pH (2 to 10) had no signifi-
cant effect on the amount of AFB1 released. Binding of
AFB1 appears to be predominantly extracellular for viable
and heat-treated bacteria. However, acid treatment may
permit intracellular binding. In all cases, binding is revers-
ible, but the stability of the complexes formed depends on
strain, treatment, and environmental conditions. Gener-
ally, detachment of AFB1, from the bacterial surface
requires time. During that time, the AFB1 records down
along the GI tract towards expulsion. This sequestration of
AFB1 reduces the opportunity for it to be reabsorbed or
exert a pathogenic effect on the enterocytes or gut-associ-
ated lymphoid tissue (GALT). This may be the net effect of
detoxifying mycotoxins from the system. Also, our results
are compatible with [36], as ochratoxin A exhibits cloudy
swelling of proximal convoluted tubules in addition to
Table 5: Effect of honey and mycotoxins on LAB growth (log10CFU/g).
Strains Mice Groups
OT HOT AT HAT NTC HTC
Lactobacilli
3.26 ± 0.19 3.83 ± 0.20 Nil Nil 5.00 ± 0.15 6.06 ± 0.22
Bifidobacteria
3.73 ± 0.19 4.77 ± 0.41 3.20 ± 0.32 3.77 ± 0.22 6.26 ± 0.29 8.57 ± 0.24BMC Complementary and Alternative Medicine 2006, 6:6 http://www.biomedcentral.com/1472-6882/6/6
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tubular eosinohilic intraluminal proteinaceous casts,
fibrin thrombi within glomerular capillary loops and
marked interstitial fibrosis and congestion.
Aflatoxins are genotoxic carcinogens. For this type of car-
cinogens, it is generally felt that there is no threshold dose
below which no tumor formation would occur. In other
words, only a zero level of exposure will result in no risk.
This agrees with the recent evaluation of [37], with respect
to the genotoxicity of the aflatoxin [38]. It is necessary to
perform in depth studies to elucidate the effect of growth
phase of all probiotic bacteria strains on AFB1 and G1
binding and other mycotoxins in vitro and in vivo.
Conclusion
The present results suggest that honey has protective
effects dependant on its antimicrobial properties. Also
honey enhances the endogenous colonic probiotic bacte-
ria (bifidogenic effects) that has several beneficial effects
(i. e. detoxification and antigenotoxicity).
We recommend that substituting sugars with honey at
high concentration in processed foods, infant formula,
children snacks especially that manufactured from agri-
culture materials (e.g. ground peas and maize) to avoid
growth of fungi and prevent formation of mycotoxins.
According to the results achieved in this paper, a dose of
aflatoxin mixture exceeding 1 µg aflatoxins/kg body
weigh/day has pronounced harmful effects. This is con-
firmed by the discussion made recently by the European
Union to reduce the maximum limits, of aflatoxins in
foods.
List of abbreviations
OT group-group 1, AIN-93 M powder diet fed and admin-
istered ochratoxin A (10 ng/kg body weight/day).
HOT group-group2, honey AIN-93 M powder diet fed
and administered ochratoxin A (10 ng/kg body weight/
day).
AT group-group 3, AIN-93 M powder diet fed and admin-
istered aflatoxins mixture (1 µg/kg body weight/day).
HAT group-group 4, honey AIN-93 M powder diet fed
and administered aflatoxins mixture (1 µg/kg body
weight/day).
NTC group-group 5, AIN-93 M powder diet fed.
HTC group-group 6, honey AIN-93 M powder diet fed.
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